Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach (Q35794457)
Jump to navigation
Jump to search
scientific article published on 22 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach |
scientific article published on 22 January 2012 |
Statements
1 reference
Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach (English)
1 reference
John C Byrd
1 reference
Kristie Blum
1 reference
Jeffrey Jones
1 reference
Michael R Grever
1 reference
Mitch A Phelps
1 reference
Deborah M Stephens
1 reference
Amy S Ruppert
1 reference
Joseph M Flynn
1 reference
Amy J Johnson
1 reference
Jia Ji
1 reference
22 January 2012
1 reference
1 reference
97
1 reference
3
1 reference
423-427
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference